Vascular Smooth Muscle Cell Phenotypic Changes in Patients With Marfan Syndrome
Author(s) -
Eva CrosasMolist,
Thayna Meirelles,
Judit LópezLuque,
Carla SerraPeinado,
Javier Selva,
Laia Caja,
Darya Gorbenko del Blanco,
Juan J. Uriarte,
Esther Bertrán,
Yolanda Mendizábal,
Vanessa Hernández,
Carolina García-Calero,
Óscar Busnadiego,
Enric Condom,
David Toral,
Manuel Castellá,
Alberto Forteza,
Daniel Navajas,
Elisabet Sarri,
Fernando RodríguezPascual,
Harry C. Dietz,
Isabel Fabregat,
Gustavo Egea
Publication year - 2015
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.114.304412
Subject(s) - myocardin , versican , extracellular matrix , vascular smooth muscle , marfan syndrome , calponin , biology , serum response factor , microbiology and biotechnology , fibrillin , transforming growth factor , myosin , actin , medicine , pathology , endocrinology , transcription factor , proteoglycan , biochemistry , smooth muscle , gene
Marfan's syndrome is characterized by the formation of ascending aortic aneurysms resulting from altered assembly of extracellular matrix microfibrils and chronic tissue growth factor (TGF)-β signaling. TGF-β is a potent regulator of the vascular smooth muscle cell (VSMC) phenotype. We hypothesized that as a result of the chronic TGF-β signaling, VSMC would alter their basal differentiation phenotype, which could facilitate the formation of aneurysms. This study explores whether Marfan's syndrome entails phenotypic alterations of VSMC and possible mechanisms at the subcellular level.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom